Searched for
EARLY STAGE TRIAL
Johnson & Johnson's prostate cancer drug shrinks tumors in early-stage trial- 14-year-old Indian American kid invents AI-powered app that can evaluate your heart health in just seven seconds. Who is Siddarth Nandyala?
- 13-year-old Kaia Minn uses orange peels to develop biodegradable seed pods that could help restore forests
- Strong majority of voters believes Trump is failing at home and abroad: AP-NORC pollFederal authorities are investigating suspicious mailings received by congressional and election offices across the country. With Election ...16 Oct, 2026, 07.32 AM IST
- AstraZeneca strikes $40 million AI drug discovery deal with insitroAstraZeneca has entered a collaboration with insitro to explore new treatment options for challenging liver and heart diseases. The partner...16 Oct, 2026, 12.53 AM IST
- This tiny injectable device could stimulate nerves without surgery, wires or batteries. Here’s what researchers still need to proveA device measuring just a few millimetres could offer a different way to stimulate nerves inside the body. Developed by researchers at NYU ...16 Oct, 2026, 12.41 AM IST
- AstraZeneca strikes $40 million AI drug discovery deal with insitroAstraZeneca has entered into a partnership with insitro to identify treatments for challenging liver and heart diseases. This collaboration...15 Oct, 2026, 04.00 PM IST
- IBM to deploy India’s first quantum computer in Amaravati early 2027The facility will focus on developing practical applications for quantum computing and helping Indian enterprises prepare their IT infrastr...14 Oct, 2026, 06.00 AM IST
- ‘Entire nation will turn Jantar Mantar’: CJP’s Abhijeet Dipke warns of nationwide protestsAbhijeet Dipke expressed intentions to protest against the ban on demonstrations at Jantar Mantar. The Delhi Police Commissioner announced ...13 Oct, 2026, 04.25 PM IST
- How a single-celled alga helped scientists control brain cells with light — the discovery behind the 2026 Nobel Prize in Medicine2026 Nobel Prize in Medicine: Peter Hegemann and Georg Nagel discovered channelrhodopsin, a light-sensitive protein in single-celled algae....06 Oct, 2026, 06.54 PM IST
- The Comeback of the Physical Store—and What It Means for Your BusinessBrick-and-mortar retail is not declining but evolving, as stores take on new roles as logistics hubs, experiential destinations, and powerf...06 Oct, 2026, 04.59 PM IST
- Who was Tammy Faye? Televangelist Jim Bakker’s first wife who helped him build a Christian TV empireTammy Faye was an American televangelist and singer known for her work with her ex-husband Jim Bakker. They established a successful Christ...06 Oct, 2026, 04.04 PM IST
- The Nobel-winning breakthrough that turned light into a remote control for the brain, allowing scientists to switch neurons on and offOptogenetics, a groundbreaking technique, enables researchers to control specific neurons using light, providing insights into brain functi...05 Oct, 2026, 10.42 PM IST
- An ECG device in a doctor’s palm: Inside Scanbo’s AI heart-screening pushSurat-based Scanbo has developed an AI-led medical device, D8, that can give a quick interpretation of abnormalities behind the functioning...04 Oct, 2026, 01.51 PM IST
- Where Does China Fit in Your Company’s Innovation Strategy?For decades, multinationals treated China primarily as either a vast growth market or a rising competitive threat. But as growth slows, com...01 Oct, 2026, 06.00 AM IST
- FDA Panel votes in favor of a $949 Cancer detecting blood test, but is Galleri ready for approval?Cancer cells can leave tiny fragments of DNA in the bloodstream. According to USA Today, Galleri studies chemical patterns found on these f...25 Sep, 2026, 05.25 PM IST
- Lord’s Mark advances AI breast cancer screening towards clinical trialsIn a groundbreaking collaboration with C-MET, Lord's Mark Industries Limited is making strides in breast cancer screening technology. Utili...25 Sep, 2026, 05.17 PM IST
- Better AI won’t fix bad company data: Fuel Cycle’s Daryush LaqabCompanies are increasingly deploying AI agents, but data quality remains a significant challenge in their effectiveness. Around 40% of larg...25 Sep, 2026, 02.43 PM IST
- Ozempic maker Novo Nordisk sets sights on hair-loss marketThe condition is part of a list of areas, including addiction and menopause, where Novo sees potential overlap with either its core scienti...23 Sep, 2026, 12.12 AM IST
- Wegovy maker Novo Nordisk faces investor pressure to find growth beyond weight-loss drugsFacing increased scrutiny, Novo Nordisk must clarify its future strategy outside of its leading weight-loss drug. Investors are advocating ...21 Sep, 2026, 11.36 AM IST
Load More
